Sleeping Beauty transposon system for genetic etiological research and gene therapy of cancers

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90; PMID:21296855; http://dx.doi.org/10.3322/caac.20107
   PubMed Web of Science ®Google Scholar
• Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446:153-8; PMID:17344846; http://dx.doi.org/10.1038/nature05610
   PubMed Web of Science ®Google Scholar
• Chitilian JM, Thillainadesan G, Manias JL, Chang WY, Walker E, Isovic M, Stanford WL, Torchia J. Critical components of the pluripotency network are targets for the p300/CBP interacting protein (p/CIP) in embryonic stem cells. Stem Cells 2014; 32:204-15; PMID:24115386; http://dx.doi.org/10.1002/stem.1564
   PubMed Web of Science ®Google Scholar
• Ivics Z, Hackett PB, Plasterk RH, Izsvak Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 1997; 91:501-10; PMID:9390559; http://dx.doi.org/10.1016/S0092-8674(00)80436-5
   PubMed Web of Science ®Google Scholar
• Miskey C, Izsvak Z, Plasterk RH, Ivics Z. The Frog Prince: a reconstructed transposon from Rana pipiens with high transpositional activity in vertebrate cells. Nucleic Acids Res 2003; 31:6873-81; PMID:14627820; http://dx.doi.org/10.1093/nar/gkg910
   PubMed Web of Science ®Google Scholar
• Urschitz J, Moisyadi S. Transpositional transgenesis with. Mob Genet Elements 2013; 3:e25167; PMID:23956948; http://dx.doi.org/10.4161/mge.25167
   PubMedGoogle Scholar
• Jursch T, Miskey C, Izsvak Z, Ivics Z. Regulation of DNA transposition by CpG methylation and chromatin structure in human cells. Mob DNA 2013; 4:15; PMID:23676100; http://dx.doi.org/10.1186/1759-8753-4-15
   PubMed Web of Science ®Google Scholar
• Pflieger A, Jaillet J, Petit A, Auge-Gouillou C, Renault S. Target capture during Mos1 transposition. J Biol Chem 2014; 289:100-11; PMID:24269942; http://dx.doi.org/10.1074/jbc.M113.523894
   PubMed Web of Science ®Google Scholar
• Meir YJ, Wu SC. Transposon-based vector systems for gene therapy clinical trials: challenges and considerations. Chang Gung Med J 2011; 34:565-79; PMID:22196059
   PubMedGoogle Scholar
• Yant SR, Park J, Huang Y, Mikkelsen JG, Kay MA. Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells. Mol Cell Biol 2004; 24:9239-47; PMID:15456893; http://dx.doi.org/10.1128/MCB.24.20.9239-9247.2004
   PubMed Web of Science ®Google Scholar
• Zayed H, Izsvak Z, Walisko O, Ivics Z. Development of hyperactive sleeping beauty transposon vectors by mutational analysis. Mol Ther 2004; 9:292-304; PMID:14759813; http://dx.doi.org/10.1016/j.ymthe.2003.11.024
   PubMed Web of Science ®Google Scholar
• Geurts AM, Yang Y, Clark KJ, Liu G, Cui Z, Dupuy AJ, Bell JB, Largaespada DA, Hackett PB. Gene transfer into genomes of human cells by the sleeping beauty transposon system. Mol Ther 2003; 8:108-17; PMID:12842434; http://dx.doi.org/10.1016/S1525-0016(03)00099-6
   PubMed Web of Science ®Google Scholar
• Izsvak Z, Khare D, Behlke J, Heinemann U, Plasterk RH, Ivics Z. Involvement of a bifunctional, paired-like DNA-binding domain and a transpositional enhancer in Sleeping Beauty transposition. J Biol Chem 2002; 277:34581-8; PMID:12082109; http://dx.doi.org/10.1074/jbc.M204001200
   PubMed Web of Science ®Google Scholar
• Ma K, Wang DD, Lin Y, Wang J, Petrenko V, Mao C. Synergetic targeted delivery of Sleeping-Beauty transposon system to mesenchymal stem cells using LPD nanoparticles modified with a phage-displayed targeting peptide. Adv Funct Mater 2013; 23:1172-81; PMID:23885226; http://dx.doi.org/10.1002/adfm.201102963
   PubMed Web of Science ®Google Scholar
• Baus J, Liu L, Heggestad AD, Sanz S, Fletcher BS. Hyperactive transposase mutants of the Sleeping Beauty transposon. Mol Ther 2005; 12:1148-56; PMID:16150650; http://dx.doi.org/10.1016/j.ymthe.2005.06.484
   PubMed Web of Science ®Google Scholar
• Mates L, Chuah MK, Belay E, Jerchow B, Manoj N, Acosta-Sanchez A, Grzela DP, Schmitt A, Becker K, Matrai J, et al. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 2009; 41:753-61; PMID:19412179; http://dx.doi.org/10.1038/ng.343
   PubMed Web of Science ®Google Scholar
• Liang Q, Kong J, Stalker J, Bradley A. Chromosomal mobilization and reintegration of Sleeping Beauty and PiggyBac transposons. Genesis 2009; 47:404-8; PMID:19391106; http://dx.doi.org/10.1002/dvg.20508
   PubMed Web of Science ®Google Scholar
• Wu SC, Meir YJ, Coates CJ, Handler AM, Pelczar P, Moisyadi S, Kaminski JM. piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells. Proc Natl Acad Sci U S A 2006; 103:15008-13; PMID:17005721; http://dx.doi.org/10.1073/pnas.0606979103
   PubMed Web of Science ®Google Scholar
• Xue X, Huang X, Nodland SE, Mates L, Ma L, Izsvak Z, Ivics Z, LeBien TW, McIvor RS, Wagner JE, et al. Stable gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood 2009; 114:1319-30; PMID:19414858; http://dx.doi.org/10.1182/blood-2009-03-210005
   PubMed Web of Science ®Google Scholar
• Dupuy AJ, Rogers LM, Kim J, Nannapaneni K, Starr TK, Liu P, Largaespada DA, Scheetz TE, Jenkins NA, Copeland NG. A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res 2009; 69:8150-6; PMID:19808965; http://dx.doi.org/10.1158/0008-5472.CAN-09-1135
   PubMed Web of Science ®Google Scholar
• Thyagarajan B, Guimaraes MJ, Groth AC, Calos MP. Mammalian genomes contain active recombinase recognition sites. Gene 2000; 244:47-54; PMID:10689186; http://dx.doi.org/10.1016/S0378-1119(00)00008-1
   PubMed Web of Science ®Google Scholar
• Semprini S, Troup TJ, Kotelevtseva N, King K, Davis JR, Mullins LJ, Chapman KE, Dunbar DR, Mullins JJ. Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques. Nucleic Acids Res 2007; 35:1402-10; PMID:17284462; http://dx.doi.org/10.1093/nar/gkl1108
   PubMed Web of Science ®Google Scholar
• Lou DQ, Molina T, Bennoun M, Porteu A, Briand P, Joulin V, Vasseur-Cognet M, Cavard C. Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences. Cancer Lett 2005; 229:107-14; PMID:16157222; http://dx.doi.org/10.1016/j.canlet.2004.12.032
   PubMed Web of Science ®Google Scholar
• Ito A, Asamoto M, Hokaiwado N, Shirai T. Regulation of cell proliferation by induction of p21/WAF1 in rat bladder carcinoma cells using the Cre–loxP system. Cancer Lett 2003; 193:183-8; PMID:12706876; http://dx.doi.org/10.1016/S0304-3835(03)00007-7
   PubMed Web of Science ®Google Scholar
• Sin YY, Ballantyne LL, Mukherjee K, St Amand T, Kyriakopoulou L, Schulze A, Funk CD. Inducible arginase 1 deficiency in mice leads to hyperargininemia and altered amino acid metabolism. PLoS One 2013; 8:e80001; PMID:24224027; http://dx.doi.org/10.1371/journal.pone.0080001
   PubMedGoogle Scholar
• Fischer JM, Schepers AG, Clevers H, Shibata D, Liskay RM. Occult progression by Apc-deficient intestinal crypts as a target for chemoprevention. Carcinogenesis 2014; 35:237-46; PMID:23996931; http://dx.doi.org/10.1093/carcin/bgt296
   PubMed Web of Science ®Google Scholar
• Dupuy AJ, Akagi K, Largaespada DA, Copeland NG, Jenkins NA. Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 2005; 436:221-6; PMID:16015321; http://dx.doi.org/10.1038/nature03691
   PubMed Web of Science ®Google Scholar
• Collier LS, Carlson CM, Ravimohan S, Dupuy AJ, Largaespada DA. Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 2005; 436:272-6; PMID:16015333; http://dx.doi.org/10.1038/nature03681
   PubMed Web of Science ®Google Scholar
• Keng VW, Villanueva A, Chiang DY, Dupuy AJ, Ryan BJ, Matise I, Silverstein KA, Sarver A, Starr TK, Akagi K, et al. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat Biotechnol 2009; 27:264-74; PMID:19234449; http://dx.doi.org/10.1038/nbt.1526
   PubMed Web of Science ®Google Scholar
• Starr TK, Allaei R, Silverstein KA, Staggs RA, Sarver AL, Bergemann TL, Gupta M, O'Sullivan MG, Matise I, Dupuy AJ, et al. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 2009; 323:1747-50; PMID:19251594; http://dx.doi.org/10.1126/science.1163040
   PubMed Web of Science ®Google Scholar
• Bell JB, Aronovich EL, Schreifels JM, Beadnell TC, Hackett PB. Duration of expression and activity of Sleeping Beauty transposase in mouse liver following hydrodynamic DNA delivery. Mol Ther 2010; 18:1796-802; PMID:20628359; http://dx.doi.org/10.1038/mt.2010.152
   PubMed Web of Science ®Google Scholar
• Yant SR, Meuse L, Chiu W, Ivics Z, Izsvak Z, Kay MA. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet 2000; 25:35-41; PMID:10802653; http://dx.doi.org/10.1038/75568
   PubMed Web of Science ®Google Scholar
• Horie K, Kuroiwa A, Ikawa M, Okabe M, Kondoh G, Matsuda Y, Takeda J. Efficient chromosomal transposition of a Tc1/mariner- like transposon Sleeping Beauty in mice. Proc Natl Acad Sci U S A 2001; 98:9191-6; PMID:11481482; http://dx.doi.org/10.1073/pnas.161071798
   PubMed Web of Science ®Google Scholar
• Carlson CM, Dupuy AJ, Fritz S, Roberg-Perez KJ, Fletcher CF, Largaespada DA. Transposon mutagenesis of the mouse germline. Genetics 2003; 165:243-56; PMID:14504232
   PubMed Web of Science ®Google Scholar
• Dupuy AJ, Fritz S, Largaespada DA. Transposition and gene disruption in the male germline of the mouse. Genesis 2001; 30:82-8; PMID:11416868; http://dx.doi.org/10.1002/gene.1037
   PubMed Web of Science ®Google Scholar
• Horie K, Yusa K, Yae K, Odajima J, Fischer SE, Keng VW, Hayakawa T, Mizuno S, Kondoh G, Ijiri T, et al. Characterization of Sleeping Beauty transposition and its application to genetic screening in mice. Mol Cell Biol 2003; 23:9189-207; PMID:14645530; http://dx.doi.org/10.1128/MCB.23.24.9189-9207.2003
   PubMed Web of Science ®Google Scholar
• Fischer SE, Wienholds E, Plasterk RH. Regulated transposition of a fish transposon in the mouse germ line. Proc Natl Acad Sci U S A 2001; 98:6759-64; PMID:11381141; http://dx.doi.org/10.1073/pnas.121569298
   PubMed Web of Science ®Google Scholar
• Dupuy AJ, Clark K, Carlson CM, Fritz S, Davidson AE, Markley KM, Finley K, Fletcher CF, Ekker SC, Hackett PB, et al. Mammalian germ-line transgenesis by transposition. Proc Natl Acad Sci U S A 2002; 99:4495-9; PMID:11904379; http://dx.doi.org/10.1073/pnas.062630599
   PubMed Web of Science ®Google Scholar
• Ohlfest JR, Frandsen JL, Fritz S, Lobitz PD, Perkinson SG, Clark KJ, Nelsestuen G, Key NS, McIvor RS, Hackett PB, et al. Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system. Blood 2005; 105:2691-8; PMID:15576475; http://dx.doi.org/10.1182/blood-2004-09-3496
   PubMed Web of Science ®Google Scholar
• Belur LR, Frandsen JL, Dupuy AJ, Ingbar DH, Largaespada DA, Hackett PB, Scott McIvor R. Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system. Mol Ther 2003; 8:501-7; PMID:12946324; http://dx.doi.org/10.1016/S1525-0016(03)00211-9
   PubMed Web of Science ®Google Scholar
• Dupuy AJ. Transposon-based screens for cancer gene discovery in mouse models. Semin Cancer Biol 2010; 20:261-8; PMID:20478384; http://dx.doi.org/10.1016/j.semcancer.2010.05.003
   PubMed Web of Science ®Google Scholar
• Keng VW, Yae K, Hayakawa T, Mizuno S, Uno Y, Yusa K, Kokubu C, Kinoshita T, Akagi K, Jenkins NA, et al. Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system. Nat Methods 2005; 2:763-9; PMID:16179923; http://dx.doi.org/10.1038/nmeth795
   PubMed Web of Science ®Google Scholar
• Karsi A, Moav B, Hackett P, Liu Z. Effects of insert size on transposition efficiency of the sleeping beauty transposon in mouse cells. Mar Biotechnol (NY) 2001; 3:241-5; PMID:14961361; http://dx.doi.org/10.1007/s101260000072
   PubMed Web of Science ®Google Scholar
• Wilson MH, Coates CJ, George AL, Jr. PiggyBac transposon-mediated gene transfer in human cells. Mol Ther 2007; 15:139-45; PMID:17164785; http://dx.doi.org/10.1038/sj.mt.6300028
   PubMed Web of Science ®Google Scholar
• Mikkelsen JG, Yant SR, Meuse L, Huang Z, Xu H, Kay MA. Helper-independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo. Mol Ther 2003; 8:654-65; PMID:14529839; http://dx.doi.org/10.1016/S1525-0016(03)00216-8
   PubMed Web of Science ®Google Scholar
• Izsvak Z, Ivics Z, Plasterk RH. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol 2000; 302:93-102; PMID:10964563; http://dx.doi.org/10.1006/jmbi.2000.4047
   PubMed Web of Science ®Google Scholar
• Dalsgaard T, Moldt B, Sharma N, Wolf G, Schmitz A, Pedersen FS, Mikkelsen JG. Shielding of sleeping beauty DNA transposon-delivered transgene cassettes by heterologous insulators in early embryonal cells. Mol Ther 2009; 17:121-30; PMID:18985029; http://dx.doi.org/10.1038/mt.2008.224
   PubMed Web of Science ®Google Scholar
• Garrison BS, Yant SR, Mikkelsen JG, Kay MA. Postintegrative gene silencing within the Sleeping Beauty transposition system. Mol Cell Biol 2007; 27:8824-33; PMID:17938204; http://dx.doi.org/10.1128/MCB.00498-07
   PubMed Web of Science ®Google Scholar
• Moldt B, Yant SR, Andersen PR, Kay MA, Mikkelsen JG. Cis-acting gene regulatory activities in the terminal regions of sleeping beauty DNA transposon-based vectors. Hum Gene Ther 2007; 18:1193-204; PMID:17988194; http://dx.doi.org/10.1089/hum.2007.099
   PubMed Web of Science ®Google Scholar
• Walisko O, Schorn A, Rolfs F, Devaraj A, Miskey C, Izsvak Z, Ivics Z. Transcriptional activities of the Sleeping Beauty transposon and shielding its genetic cargo with insulators. Mol Ther 2008; 16:359-69; PMID:18071335; http://dx.doi.org/10.1038/sj.mt.6300366
   PubMed Web of Science ®Google Scholar
• Liu G, Aronovich EL, Cui Z, Whitley CB, Hackett PB. Excision of Sleeping Beauty transposons: parameters and applications to gene therapy. J Gene Med 2004; 6:574-83; PMID:15133768; http://dx.doi.org/10.1002/jgm.486
   PubMed Web of Science ®Google Scholar
• Izsvak Z, Stuwe EE, Fiedler D, Katzer A, Jeggo PA, Ivics Z. Healing the wounds inflicted by sleeping beauty transposition by double-strand break repair in mammalian somatic cells. Mol Cell 2004; 13:279-90; PMID:14759372; http://dx.doi.org/10.1016/S1097-2765(03)00524-0
   PubMed Web of Science ®Google Scholar
• Yant SR, Kay MA. Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cells. Mol Cell Biol 2003; 23:8505-18; PMID:14612396; http://dx.doi.org/10.1128/MCB.23.23.8505-8518.2003
   PubMed Web of Science ®Google Scholar
• Elick TA, Bauser CA, Fraser MJ. Excision of the piggyBac transposable element in vitro is a precise event that is enhanced by the expression of its encoded transposase. Genetica 1996; 98:33-41; PMID:8765680; http://dx.doi.org/10.1007/BF00120216
   PubMed Web of Science ®Google Scholar
• Thibault ST, Singer MA, Miyazaki WY, Milash B, Dompe NA, Singh CM, Buchholz R, Demsky M, Fawcett R, Francis-Lang HL, et al. A complementary transposon tool kit for Drosophila melanogaster using P and piggyBac. Nat Genet 2004; 36:283-7; PMID:14981521; http://dx.doi.org/10.1038/ng1314
   PubMed Web of Science ®Google Scholar
• Van Dyke T, Jacks T. Cancer modeling in the modern era: progress and challenges. Cell 2002; 108:135-44; PMID:11832204; http://dx.doi.org/10.1016/S0092-8674(02)00621-9
   PubMed Web of Science ®Google Scholar
• Quintana RM, Dupuy AJ, Bravo A, Casanova ML, Alameda JP, Page A, Sánchez-Viera M, Ramírez A, Navarro M. A transposon-based analysis of gene mutations related to skin cancer development. J Invest Dermatol 2013; 133:239-48; PMID:22832494; http://dx.doi.org/10.1038/jid.2012.245
   PubMed Web of Science ®Google Scholar
• O'Donnell KA, Keng VW, York B, Reineke EL, Seo D, Fan D, Silverstein KA, Schrum CT, Xie WR, Mularoni L, et al. A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. Proc Natl Acad Sci U S A 2012; 109:E1377-86; PMID:22556267; http://dx.doi.org/10.1073/pnas.1115433109
   PubMed Web of Science ®Google Scholar
• Mann KM, Ward JM, Yew CC, Kovochich A, Dawson DW, Black MA, Brett BT, Sheetz TE, Dupuy AJ, Australian Pancreatic Cancer Genome I, et al. Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. Proc Natl Acad Sci U S A 2012; 109:5934-41; PMID:22421440; http://dx.doi.org/10.1073/pnas.1202490109
   PubMed Web of Science ®Google Scholar
• Rahrmann EP, Watson AL, Keng VW, Choi K, Moriarity BS, Beckmann DA, Wolf NK, Sarver A, Collins MH, Moertel CL, et al. Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nat Genet 2013; 45:756-66; PMID:23685747; http://dx.doi.org/10.1038/ng.2641
   PubMed Web of Science ®Google Scholar
• Wu X, Northcott PA, Dubuc A, Dupuy AJ, Shih DJ, Witt H, Croul S, Bouffet E, Fults DW, Eberhart CG, et al. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 2012; 482:529-33; PMID:22343890; http://dx.doi.org/10.1038/nature10825
   PubMed Web of Science ®Google Scholar
• Carlson CM, Frandsen JL, Kirchhof N, McIvor RS, Largaespada DA. Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse. Proc Natl Acad Sci U S A 2005; 102:17059-64; PMID:16286660; http://dx.doi.org/10.1073/pnas.0502974102
   PubMed Web of Science ®Google Scholar
• Jung S, Ro SW, Jung G, Ju HL, Yu ES, Son WC. Sleeping Beauty transposon system harboring HRAS, c-Myc and shp53 induces sarcomatoid carcinomas in mouse skin. Oncol Rep 2013; 29:1293-8; PMID:23380875
   PubMed Web of Science ®Google Scholar
• Kitada K, Keng VW, Takeda J, Horie K. Generating mutant rats using the Sleeping Beauty transposon system. Methods 2009; 49:236-42; PMID:19398007; http://dx.doi.org/10.1016/j.ymeth.2009.04.010
   PubMed Web of Science ®Google Scholar
• Park JS, Kim BH, Park SG, Jung SY, Lee do H, Son WC. Induction of rat liver tumor using the Sleeping Beauty transposon and electroporation. Biochem Biophys Res Commun 2013; 434:589-93; PMID:23583385; http://dx.doi.org/10.1016/j.bbrc.2013.03.119
   PubMed Web of Science ®Google Scholar
• Garrels W, Mates L, Holler S, Dalda A, Taylor U, Petersen B, Niemann H, Izsvak Z, Ivics Z, Kues WA. Germline transgenic pigs by Sleeping Beauty transposition in porcine zygotes and targeted integration in the pig genome. PLoS One 2011; 6:e23573; PMID:21897845; http://dx.doi.org/10.1371/journal.pone.0023573
   PubMed Web of Science ®Google Scholar
• Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, Ren WH, Long XD, Zhang H, Ma XP, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 2013; 45:72-5; PMID:23242368; http://dx.doi.org/10.1038/ng.2483
   PubMed Web of Science ®Google Scholar
• Nam RK, Zhang W, Siminovitch K, Shlien A, Kattan MW, Klotz LH, Trachtenberg J, Lu Y, Zhang J, Yu C, et al. New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort. Cancer Biol Ther 2011; 12:997-1004; PMID:22130093; http://dx.doi.org/10.4161/cbt.12.11.18366
   PubMed Web of Science ®Google Scholar
• Kashyap MK, Marimuthu A, Kishore CJ, Peri S, Keerthikumar S, Prasad TS, Mahmood R, Rao S, Ranganathan P, Sanjeeviah RC, et al. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biol Ther 2009; 8:36-46; PMID:18981721; http://dx.doi.org/10.4161/cbt.8.1.7090
   PubMed Web of Science ®Google Scholar
• Aquino G, Pannone G, Santoro A, Liguori G, Franco R, Serpico R, Florio G, De Rosa A, Mattoni M, Cozza V, et al. pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlations. Cancer Biol Ther 2012; 13:967-77; PMID:22825335; http://dx.doi.org/10.4161/cbt.20991
   PubMed Web of Science ®Google Scholar
• Lappalainen T, Sammeth M, Friedlander MR, t Hoen PA, Monlong J, Rivas MA, Gonzalez-Porta M, Kurbatova N, Griebel T, Ferreira PG, et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 2013; 501:506-11; PMID:24037378; http://dx.doi.org/10.1038/nature12531
   PubMed Web of Science ®Google Scholar
• Keng VW, Tschida BR, Bell JB, Largaespada DA. Modeling hepatitis B virus X-induced hepatocellular carcinoma in mice with the Sleeping Beauty transposon system. Hepatology 2011; 53:781-90; PMID:21374658; http://dx.doi.org/10.1002/hep.24091
   PubMed Web of Science ®Google Scholar
• Emerenciano M, Kowarz E, Karl K, de Almeida Lopes B, Scholz B, Bracharz S, Meyer C, Pombo-de-Oliveira MS, Marschalek R. Functional analysis of the two reciprocal fusion genes MLL-NEBL and NEBL-MLL reveal their oncogenic potential. Cancer Lett 2013; 332:30-4; PMID:23340173; http://dx.doi.org/10.1016/j.canlet.2012.12.023
   PubMed Web of Science ®Google Scholar
• Riordan JD, Keng VW, Tschida BR, Scheetz TE, Bell JB, Podetz-Pedersen KM, Moser CD, Copeland NG, Jenkins NA, Roberts LR, et al. Identification of rtl1, a retrotransposon-derived imprinted gene, as a novel driver of hepatocarcinogenesis. PLoS Genet 2013; 9:e1003441; PMID:23593033; http://dx.doi.org/10.1371/journal.pgen.1003441
   PubMedGoogle Scholar
• Rahrmann EP, Collier LS, Knutson TP, Doyal ME, Kuslak SL, Green LE, Malinowski RL, Roethe L, Akagi K, Waknitz M, et al. Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen. Cancer Res 2009; 69:4388-97; PMID:19401450; http://dx.doi.org/10.1158/0008-5472.CAN-08-3901
   PubMed Web of Science ®Google Scholar
• Dey J, Dubuc AM, Pedro KD, Thirstrup D, Mecham B, Northcott PA, Wu X, Shih D, Tapscott SJ, LeBlanc M, et al. MyoD is a tumor suppressor gene in medulloblastoma. Cancer Res 2013; 73:6828-37; PMID:24092238; http://dx.doi.org/10.1158/0008-5472.CAN-13-0730-T
   PubMed Web of Science ®Google Scholar
• Mumert M, Dubuc A, Wu X, Northcott PA, Chin SS, Pedone CA, Taylor MD, Fults DW. Functional genomics identifies drivers of medulloblastoma dissemination. Cancer Res 2012; 72:4944-53; PMID:22875024; http://dx.doi.org/10.1158/0008-5472.CAN-12-1629
   PubMed Web of Science ®Google Scholar
• Huang X, Guo H, Kang J, Choi S, Zhou TC, Tammana S, Lees CJ, Li ZZ, Milone M, Levine BL, et al. Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies. Mol Ther 2008; 16:580-9; PMID:18227839; http://dx.doi.org/10.1038/sj.mt.6300404
   PubMed Web of Science ®Google Scholar
• Singh H, Manuri PR, Olivares S, Dara N, Dawson MJ, Huls H, Hackett PB, Kohn DB, Shpall EJ, Champlin RE, et al. Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system. Cancer Res 2008; 68:2961-71; PMID:18413766; http://dx.doi.org/10.1158/0008-5472.CAN-07-5600
   PubMed Web of Science ®Google Scholar
• Kebriaei P, Huls H, Jena B, Munsell M, Jackson R, Lee DA, Hackett PB, Rondon G, Shpall E, Champlin RE, et al. Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies. Hum Gene Ther 2012; 23:444-50; PMID:22107246; http://dx.doi.org/10.1089/hum.2011.167
   PubMed Web of Science ®Google Scholar
• Torikai H, Reik A, Liu PQ, Zhou Y, Zhang L, Maiti S, Huls H, Miller JC, Kebriaei P, Rabinovitch B, et al. A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. Blood 2012; 119:5697-705; PMID:22535661; http://dx.doi.org/10.1182/blood-2012-01-405365
   PubMed Web of Science ®Google Scholar
• Peng PD, Cohen CJ, Yang S, Hsu C, Jones S, Zhao Y, Zheng Z, Rosenberg SA, Morgan RA. Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity. Gene Ther 2009; 16:1042-9; PMID:19494842; http://dx.doi.org/10.1038/gt.2009.54
   PubMed Web of Science ®Google Scholar
• Huang G, Yu L, Cooper LJ, Hollomon M, Huls H, Kleinerman ES. Genetically modified T cells targeting interleukin-11 receptor alpha-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases. Cancer Res 2012; 72:271-81; PMID:22075555; http://dx.doi.org/10.1158/0008-5472.CAN-11-2778
   PubMed Web of Science ®Google Scholar
• Belur LR, Podetz-Pedersen KM, Sorenson BS, Hsu AH, Parker JB, Carlson CS, Saltzman DA, Ramakrishnan S, McIvor RS. Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System. Mol Cancer 2011; 10:14; PMID:21310067; http://dx.doi.org/10.1186/1476-4598-10-14
   PubMed Web of Science ®Google Scholar
• Ohlfest JR, Demorest ZL, Motooka Y, Vengco I, Oh S, Chen E, Scappaticci FA, Saplis RJ, Ekker SC, Low WC, et al. Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma. Mol Ther 2005; 12:778-88; PMID:16150649; http://dx.doi.org/10.1016/j.ymthe.2005.07.689
   PubMed Web of Science ®Google Scholar
• Song J, Kim C, Ochoa ER. Sleeping Beauty-mediated suicide gene therapy of hepatocellular carcinoma. Biosci Biotechnol Biochem 2009; 73:165-8; PMID:19129627; http://dx.doi.org/10.1271/bbb.80581
   PubMed Web of Science ®Google Scholar
• Wu A, Oh S, Ericson K, Demorest ZL, Vengco I, Gharagozlou S, Chen W, Low WC, Ohlfest JR. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma. Cancer Gene Ther 2007; 14:550-60; PMID:17415381; http://dx.doi.org/10.1038/sj.cgt.7701045
   PubMed Web of Science ®Google Scholar
• Clinical Trials Use Sleeping Beauty Gene Transfer to Create CAR T cells [ Internet]. Houston, TX, USA: MD Anderson Cancer Center; 2013 Dec 8. 1 p. Available from: http://www.mdanderson.org/newsroom/news-releases/2013/car-t-cells.html
   Google Scholar